4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001714899-22-000133
Director sold 20,000 shares at an average $30.82 ($616,304)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Tessier-Lavigne Marc Director | 2022-09-28 | Sale | −15,577 | $30.74 | $478,837 | 1,914,779 | D |
| Tessier-Lavigne Marc Director | 2022-09-28 | Sale | −4,423 | $31.08 | $137,467 | 1,910,356 | D |
| Open-market sales · 20,000 sh · avg $30.82 · $616,304 | |||||||
Loading xslF345X03/wf-form4_166457103687475.xml…